Your cart is currently empty!
Category: Pancreatic Cancer
Gemcitabine
Description
This page contains brief details about the drug gemcitabine, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
The U.S. FDA approved Gemcitabine as a chemotherapeutic anticancer medication to treat bladder, breast, ovarian, pancreatic, and non-small cell lung cancers on 10th January 1995.
Mechanism of Action of Gemcitabine
Gemcitabine is a cytotoxic agent belonging to the category of medications called antimetabolites. It inhibits DNA polymerase enzyme, breaks the DNA strands, interferes with cell signalling and eventually prevents the multiplication of cancer cells. Gemcitabine is prescribed alone and also in combination with other anticancer medications like Cisplatin and Carboplatin.
Uses of Gemcitabine
Gemcitabine has been developed to treat ovarian cancer, breast cancer, non-small cell lung cancer, and pancreatic cancer in patients who have failed to respond to previous therapies.
Gemcitabine Dosage available
Gemcitabine is available for administration as an intravenous infusion that is injected through the veins of patients with ovarian, breast, and non-small cell lung cancer. Your physician will choose the dosage and administration frequency based on your medical condition and type of cancer because it differs for each person.
Erlonitib
25MG,100MG,150MG Tablets Erlotinib
25MG; 100MG; 150MG Tablets Fluorouracil
Description
This page contains brief details about the drug fluorouracil, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Fluorouracil contains the active ingredient Fluorouracil. It belongs to a class of drugs called antimetabolites, which interfere with the genetic material (DNA and RNA) synthesis of rapidly dividing cancer cells, leading to their death. This medication is commonly used to treat breast, colorectal, stomach, esophagus, and pancreatic cancers. It can be administered in different ways, including through injection or as a cream.
Fluorouracil (5-fluorouracil or 5-FU) was first approved by the US Food and Drug Administration (FDA) in 1959 for treating colon and rectal cancer. Since then, it has been approved for treating other types of cancer, including breast, stomach, and pancreatic cancer. The drug is also approved in many other countries around the world. Over the years, many studies proved the effectiveness of fluorouracil in combination with other cancer treatments, and the drug continues to be an important chemotherapy medication for cancer patients.
Mechanism of Action of Fluorouracil
Fluorouracil work by interfering with the DNA and RNA synthesis of rapidly dividing cancer cells, leading to their death. It is an antimetabolite chemotherapy drug that mimics the structure of normal DNA and RNA building blocks. Still, its incorporation into DNA and RNA leads to errors in formation and causes damage to the DNA and RNA strands.
Uses of Fluorouracil
Fluorouracil is a chemotherapy medication commonly used to treat different types of cancer, including breast, colon, rectal, stomach, and pancreatic cancers. It works by interfering with the growth and division of cancer cells, ultimately causing them to die.
Fluorouracil Dosage available
Fluorouracil is a medication typically administered under a healthcare provider’s supervision, usually in a hospital or clinic setting. The method of administration can vary depending on the type of cancer and the individual patient’s condition. The injection can be given in a vein (intravenous) or muscle (intramuscular) injection. If a patient misses a scheduled dose, they should contact their healthcare provider immediately to determine the next steps. Sometimes, the missed dose may be rescheduled, or a new treatment plan may be recommended. It is important to follow the healthcare provider’s instructions closely and not make any changes to the treatment plan without first consulting with them. Patients should never take a double dose to make up for a missed dose, as this can increase the risk of side effects and toxicity.
5FU GLS
Description
This page contains brief details about the drug fluorouracil, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Fluorouracil contains the active ingredient Fluorouracil. It belongs to a class of drugs called antimetabolites, which interfere with the genetic material (DNA and RNA) synthesis of rapidly dividing cancer cells, leading to their death. This medication is commonly used to treat breast, colorectal, stomach, esophagus, and pancreatic cancers. It can be administered in different ways, including through injection or as a cream.
Fluorouracil (5-fluorouracil or 5-FU) was first approved by the US Food and Drug Administration (FDA) in 1959 for treating colon and rectal cancer. Since then, it has been approved for treating other types of cancer, including breast, stomach, and pancreatic cancer. The drug is also approved in many other countries around the world. Over the years, many studies proved the effectiveness of fluorouracil in combination with other cancer treatments, and the drug continues to be an important chemotherapy medication for cancer patients.
Mechanism of Action of Fluorouracil
Fluorouracil work by interfering with the DNA and RNA synthesis of rapidly dividing cancer cells, leading to their death. It is an antimetabolite chemotherapy drug that mimics the structure of normal DNA and RNA building blocks. Still, its incorporation into DNA and RNA leads to errors in formation and causes damage to the DNA and RNA strands.
Uses of Fluorouracil
Fluorouracil is a chemotherapy medication commonly used to treat different types of cancer, including breast, colon, rectal, stomach, and pancreatic cancers. It works by interfering with the growth and division of cancer cells, ultimately causing them to die.
Fluorouracil Dosage available Fluorouracil is a medication typically administered under a healthcare provider’s supervision, usually in a hospital or clinic setting. The method of administration can vary depending on the type of cancer and the individual patient’s condition. The injection can be given in a vein (intravenous) or muscle (intramuscular) injection. If a patient misses a scheduled dose, they should contact their healthcare provider immediately to determine the next steps. Sometimes, the missed dose may be rescheduled, or a new treatment plan may be recommended. It is important to follow the healthcare provider’s instructions closely and not make any changes to the treatment plan without first consulting with them. Patients should never take a double dose to make up for a missed dose, as this can increase the risk of side effects and toxicity.